NICE approves new cholesterol lowering drug after NHS strikes deal with manufacturer
A novel anti-cholesterol drug, to be given in primary care as a twice yearly injection, has been recommended for people with primary hypercholesterolaemia or mixed dyslipidaemia who have had a…
